Scarica l'app Stockscreener
71.93
2.63%
-1.94
Dopo l'orario di chiusura:
71.93
Precedente Chiudi:
$73.87
Aprire:
$73.75
Volume 24 ore:
1.38M
Relative Volume:
1.48
Capitalizzazione di mercato:
$4.76B
Reddito:
Utile/perdita netta:
$-116.25M
Rapporto P/E:
-30.08
EPS:
-2.3912
Flusso di cassa netto:
$-91.19M
1 W Prestazione:
-12.40%
1M Prestazione:
-23.11%
6M Prestazione:
+7.25%
1 anno Prestazione:
+170.82%
Intervallo 1D:
$70.50
$74.26
Intervallo di 1 settimana:
$70.50
$82.95
Portata 52W:
$25.11
$115.52
Oruka Therapeutics Inc Stock (ORKA) Company Profile
Nome
Oruka Therapeutics Inc
Settore
Industria
Telefono
650-606-7910
Indirizzo
855 OAK GROVE AVE., MENLO PARK
Compare ORKA vs VRTX, MRNA, REGN, ARGX, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORKA
Oruka Therapeutics Inc
|
71.93 | 4.76B | 0 | -116.25M | -91.19M | -2.3912 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-18 | Iniziato | Piper Sandler | Overweight |
| 2025-11-13 | Iniziato | Jefferies | Buy |
| 2025-10-27 | Iniziato | Guggenheim | Buy |
| 2025-10-13 | Iniziato | Barclays | Overweight |
| 2025-05-22 | Iniziato | BTIG Research | Buy |
| 2025-02-04 | Iniziato | Wolfe Research | Outperform |
| 2024-10-11 | Iniziato | Stifel | Buy |
| 2024-10-07 | Iniziato | H.C. Wainwright | Buy |
| 2024-09-17 | Iniziato | Leerink Partners | Outperform |
| 2024-09-16 | Iniziato | TD Cowen | Buy |
| 2024-09-13 | Iniziato | Jefferies | Buy |
| 2018-02-27 | Iniziato | Ascendiant Capital Markets | Buy |
| 2013-10-09 | Iniziato | Dawson James | Buy |
Mostra tutto
Oruka Therapeutics Inc Borsa (ORKA) Ultime notizie
These 2 Stocks Have Run Circles Around the Magnificent Seven This Year, and Wall Street Says There Is More Upside Ahead - The Motley Fool
Oruka Therapeutics senior vice president Arjun Agarwal sells $805,888 in stock - Investing.com
Form 4 Oruka Therapeutics Inc: Arjun Agarwal (Senior Vice President, Finance) For: 12 October - Investing.com India
Form 4 Oruka Therapeutics Inc: Arjun Agarwal (Senior Vice President, Finance) For: 12 October - Investing.com UK
Oruka Therapeutics' Arjun Agarwal Executes Option Exercises and Sells Nearly 10,000 Shares - Kalkine Media
An officer proposes selling 9,999 Oruka Therapeutics (ORKA) shares acquired through stock options. - Stock Titan
Form 4 Oruka Therapeutics Inc For: 2 October By Investing.com - Investing.com South Africa
Oruka Therapeutics (ORKA) CEO Lawrence Klein Sells 25,000 Shares - GuruFocus
Oruka Therapeutics CEO Klein sells $2.09m in stock - Investing.com
Form 4 Oruka Therapeutics Inc For: 2 October By Investing.com - Investing.com Nigeria
25,000 shares from a stock-option exercise are proposed for sale at Oruka Therapeutics (NASDAQ: ORKA). - Stock Titan
Oruka Therapeutics Announces Positive Week 28 Data for ORKA-001 from the Ongoing EVERLAST-A Trial Showing Deepening of Responses Without Additional Dosing - GlobeNewswire Inc.
Oruka Therapeutics general counsel Paul Quinlan sells $936k in stock - Investing.com Nigeria
Form 4 Oruka Therapeutics Inc For: 22 September By Investing.com - Investing.com Nigeria
Form 4 Oruka Therapeutics Inc For: 22 September By Investing.com - Investing.com Canada
Oruka Therapeutics general counsel Paul Quinlan sells $936k in stock - Investing.com Canada
Form 4 Oruka Therapeutics Inc For: 22 September - Investing.com India
Oruka Therapeutics general counsel Paul Quinlan sells $936k in stock - Investing.com
Details on Warrant Exercise and Subsequent Share Sales by Oruka Therapeutics' General Counsel - Kalkine Media
Oruka Therapeutics SVP Arjun Agarwal Sells 533 Shares Under Rule 10b5-1 Plan - Kalkine Media
Oruka Therapeutics SVP Arjun Agarwal sells $51,034 in ORKA stock - Investing.com
Oruka Therapeutics SVP Arjun Agarwal sells $51,034 in ORKA stock By Investing.com - Investing.com South Africa
Oruka Therapeutics SVP Arjun Agarwal sells $51,034 in ORKA stock By Investing.com - Investing.com Nigeria
Oruka Therapeutics (NASDAQ: ORKA) insider plans new share sale after recent 10b5-1 trades - Stock Titan
Oruka Therapeutics SVP Agarwal sells over $926k in common stock By Investing.com - Investing.com South Africa
Oruka Therapeutics SVP Agarwal sells over $926k in common stock - Investing.com India
Oruka Therapeutics general counsel Paul Quinlan sells $99,442 in stock - Investing.com
Oruka Therapeutics CEO Lawrence Klein sells $234,680 in ORKA stock - Investing.com
Oruka Therapeutics general counsel Paul Quinlan sells $99,442 in stock By Investing.com - Investing.com Canada
Oruka Therapeutics COO Sandler sells $86,713 in common stock - Investing.com
Oruka (ORKA) legal chief sells shares to cover RSU taxes - Stock Titan
Oruka (ORKA) finance SVP sells 10K shares after option exercises - Stock Titan
Oruka Therapeutics to Attend Morgan Stanley Global Healthcare Conference - Bitget
Morgan Stanley's New York healthcare conference includes Oruka - Stock Titan
Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference - GlobeNewswire
About Oruka Therapeutics Inc aStock - Coinbase
H.C. Wainwright reiterates Oruka Therapeutics stock rating at buy By Investing.com - Investing.com Canada
H.C. Wainwright reiterates Oruka Therapeutics stock rating at buy - Investing.com UK
UBS Maintains Oruka Therapeutics(ORKA.US) With Buy Rating, Maintains Target Price $130 - Moomoo
Oruka Therapeutics CEO Klein sells $6.8m in stock By Investing.com - Investing.com South Africa
Oruka Therapeutics COO Laura Sandler sells $459,101 in stock By Investing.com - Investing.com South Africa
Oruka Therapeutics(ORKA.US) Officer Sells US$6.89 Million in Common Stock - Moomoo
Oruka Therapeutics COO Laura Sandler sells $459,101 in stock By Investing.com - Investing.com Nigeria
Oruka Therapeutics CEO Klein sells $6.8m in stock By Investing.com - Investing.com Nigeria
Oruka Therapeutics COO Laura Sandler sells $459,101 in stock - Investing.com
Oruka Therapeutics CEO Klein sells $6.8m in stock - Investing.com
Oruka Therapeutics COO Laura Sandler sells $459,101 in stock - Investing.com India
Oruka Therapeutics COO Laura Sandler sells $459,101 in stock By Investing.com - Investing.com Canada
Oruka Therapeutics CEO Klein sells $6.8m in stock - Investing.com UK
Insider at Oruka Therapeutics (ORKA) plans stock sale from option exercise - Stock Titan
Oruka Therapeutics Inc Azioni (ORKA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Oruka Therapeutics Inc Azioni (ORKA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Goncalves Joana | Chief Medical Officer |
Oct 15 '26 |
Sale |
74.81 |
7,000 |
523,648 |
31,771 |
| JOANA GONCALVES | Officer |
Oct 15 '26 |
Proposed Sale |
76.68 |
21,000 |
1,610,280 |
0 |
| Agarwal Arjun | Senior Vice President, Finance |
Oct 12 '26 |
Option Exercise |
15.69 |
9,999 |
156,903 |
24,218 |
| Agarwal Arjun | Senior Vice President, Finance |
Oct 12 '26 |
Sale |
80.60 |
9,999 |
805,889 |
14,219 |
| Arjun Agarwal | Officer |
Oct 12 '26 |
Proposed Sale |
82.11 |
9,999 |
821,018 |
0 |
| Klein Lawrence Otto | Chief Executive Officer |
Oct 01 '26 |
Sale |
83.62 |
25,000 |
2,090,593 |
923,128 |
| LAWRENCE KLEIN | Director |
Oct 01 '26 |
Proposed Sale |
83.29 |
25,000 |
2,082,250 |
0 |
| Klein Lawrence Otto | Chief Executive Officer |
Oct 01 '26 |
Option Exercise |
7.80 |
25,000 |
195,000 |
948,128 |
| Arjun Agarwal | Officer |
Sep 21 '26 |
Proposed Sale |
94.96 |
533 |
50,614 |
0 |
| Quinlan Paul T | General Counsel |
Sep 21 '26 |
Option Exercise |
7.80 |
10,000 |
78,000 |
39,995 |
9.95%
0.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):